Agios Pharmaceuticals (AGIO) is pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias (a blood condition that occurs when your red blood cells are destroyed faster than they can be replaced). The science is above my pay grade but the chart is showing a base pattern so it has my attention.
More from Investing
I'm AMPD About This ETF
The CNIC ICE U.S. Carbon Neutral Power Futures Index exchange-traded fund provides exposure to a blended national electricity price and carbon credits.
Belly Up to the Bar and Be a Buyer of Molson Coors
Here's where the charts indicate the stock may be headed.
Play Unity Software This Way as the Stock Surges on Apple Vision Pro Partnership
Clues were out there, but the news certainly took most by surprise.
OK, I'll Bite. Should I Nibble on Chewy or Petco?
Here's why I favor one for technical and fundamental reasons.